Improving Compliance With Metformin

Diabetes Clinical Trial

Official title:

Improving Compliance With Metformin

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00018616
• Other study ID #: MHBS-047-98F
• Status: Completed
• Phase: Phase 2
• First received: July 3, 2001
• Last updated: September 21, 2009
• Start date: October 1999
• Est. completion date: January 2005

Study information

• Verified date: September 2009
• Source: VA Office of Research and Development
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

This is a randomized controlled trial of adherence. The study involves monitoring and managing focused intervention in patients prescribed metformin.

Description:

The active intervention, MEMS Feedback, involves review of patients' medication-taking over the preceding weeks

Recruitment information / eligibility

• Status: Completed
• Enrollment: 79
• Est. completion date: January 2005
• Est. primary completion date: January 2004
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Metformin has been prescribed

• Willing to use medication containers with MEMS caps

• Capable of giving informed consent

Exclusion Criteria:

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label

Related Conditions & MeSH terms

• Diabetes

Intervention

Behavioral:
• MEMS caps

Locations

Country	Name	City	State
United States	VA Connecticut Health Care System (West Haven)	West Haven	Connecticut

Sponsors (1)

Lead Sponsor	Collaborator
VA Office of Research and Development

Country where clinical trial is conducted

United States,